Stay updated on Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A banner was added announcing an NIH website transition and linking to updates and FAQs. It appears above the 403 error page.
    Difference
    1%
    Check dated 2026-10-25T13:19:17.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The displayed site revision changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T13:27:38.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T14:43:06.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content and navigation for this URL. Access to the study details is blocked.
    Difference
    19%
    Check dated 2026-09-20T22:36:29.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The revision level was updated from v3.6.5 to v3.6.6, indicating a software update to the site. There are no described changes to the study content or page functionality.
    Difference
    0.1%
    Check dated 2026-08-30T17:40:08.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    Adds the new revision identifier Revision: v3.6.5 to the page's metadata. Removes the previous Revision: v3.6.4, reflecting a version update.
    Difference
    0.1%
    Check dated 2026-08-09T12:23:31.000Z thumbnail image

Stay in the know with updates to Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial page.